Cite Score:
0.73
CITE SCORE SCOPUS

Chlamydia trachomatis Detection by Nested-PCR Method on Females Referred to Medical Centers of Tehran, Iran

AUTHORS

Gita Eslami 1 , Hossein Goudarzi 1 , Robabeh Taheripanah 2 , Soudabeh Taheri 1 , Fatemeh Fallah 1 , Bahram Moazzami 3 , Arezou Taherpour 1 , Elnaz Ohadi 1 , Bita Pourkaveh 4 , Zahra Zahirnia 1 , *

1 Department of Microbiology, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran

2 Department of Infertility and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran

3 Managment Office, Pars Hospital, Tehran, IR Iran

4 Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran

How to Cite: Eslami G, Goudarzi H, Taheripanah R, Taheri S, Fallah F, et al. Chlamydia trachomatis Detection by Nested-PCR Method on Females Referred to Medical Centers of Tehran, Iran, Arch Clin Infect Dis. 2012 ; 7(4):124-7. doi: 10.5812/archcid.15087.

ARTICLE INFORMATION

Archives of Clinical Infectious Diseases: 7 (4); 124-7
Published Online: October 5, 2012
Article Type: Research Article
Received: September 15, 2012
Revised: September 20, 2012
Accepted: September 29, 2012
Crossmark

Crossmark

CHEKING

READ FULL TEXT
Abstract

Background: Chlamydia trachomatis (C. trachomatis) is the most common sexually transmitted bacterial infectious disease in the world. Moreover, it plays a role in spontaneous abortion. The accuracy of PCR in detection of C. trachomatis infections has been shown in several studies.

Objectives: The frequency of spontaneous abortion and known side effects and statistics vary in Chlamydia trachomatis infection in women with spontaneous abortion and different ways to identify and determine the prevalence of Chlamydia trachomatis are used.

Materials and Methods: Four sterile Dacron swabs were used to collect specimens from endocervix and vagina from women with miscarriage. DNA was extracted by AccuPrep Genomic DNA extraction kit. The nested PCR procedure was performed with two pair primers. This study was conducted on women referred to Medical Centers of Tehran, Iran in 1391.

Results: The number of intercourses per week and history of miscarriage can be known as the risk factors of abortion. Frequency of C. trachomatis in endocervix was 13.25%; the amount of vaginal infection among this group was 19%.

Conclusions: Nested PCR as a sensitive Chlamydia trachomatis detection test and endocervical specimens has been offered to detect this bacterium in spontaneous abortion. Besides, C. trachomatis screening among pregnant women can be suggested to prevent abortion.

Keywords

Chlamydia trachomatis Abortion, Spontaneous Polymerase Chain Reaction

Copyright © 2012, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

1. Background

One of the appropriate anatomical places for the growth of many micro-organisms in woman body is the genital tract. Chlamydia trachomatis, Ureaplasma urealyticum, Gardnerella vaginalis, Listeria monocytogenes and Neisseria gonorrhoeae are some of the bacteria localize in female genital tract (1). Chlamydia trachomatis (C. trachomatis) is the most causative agent of bacterial sexually transmitted infections (STI) (2, 3). There are about 90 million cases with STI throughout the world, annually (3). It can cause cervicitis, pelvic inflammatory disease (PID), and urethritis in women (4). However, most of contaminations with C. trachomatis remain undetectable (70% - 80%), because these cases are often asymptomatic (5). C. trachomatis in pregnant women increases the risk of ectopic pregnancy, spontaneous abortion, premature rupture of membranes, postpartum endometritis, perinatal mortality and low birth weight (6). Moreover, pathogenesis of Chlamydia trachomatis in abortion has been determined (2, 7).

C. trachomatis is a gram negative, pleomorphic, intracellular and nonmotile organism with about 0.2 - 1.5 µm length (8, 9). C. trachomatis detection tests are divided in two groups; cell culture and non-cultural tests. Cell culture facilities do in specialized research laboratories only. Non-cultural cells such as enzyme immunoassays (EIAs), serological tests have no enough accuracy, sensitivity and specificity to diagnosis of C. trachomatis infections (10). Polymerase chain reaction (PCR) and ligase chain reaction (LCR) have been offered for detection of C. trachomatis (10, 11). Accuracy of nucleic acid amplification tests (NAATs) in detection of C. trachomatis infections have been shown in several studies (11, 12). The specificity of the PCR was 100% and the sensitivity was 100% (13).

2. Objectives

The aim of this study is to evaluate the C. trachomatis infection frequency by nested-PCR method among women with abortion in Tehran, Iran.

3. Materials and Methods

Specimen collection: from November 2011 to September 2012, 121 women were enrolled in this study; they had been referred to medical centers, Shahid Beheshti University of Medical Sciences, Tehran - Iran. Questionnaires were filled for each person. By using speculum, 4 sterile Dacron swabs were used to collect specimens from endocervix and vagina. Two Swabs were placed in 0.2 M sucrose phosphate (2 SP, pH = 7.2) buffer tubes with 10% fetal bovin serum, antibiotics (Streptomycin 50µg/mL + Ancomycin 100 µg/mL + Gentamicin 10µg/mL; Sigma Co.) (14) and two swabs for other bacteria. All specimens were transported on ice to the microbiology research laboratory of Shahid Beheshti University. All specimens were stored at -70°C until DNA extraction.

DNA extraction: DNA extraction was performed by AccuPrep Genomic DNA Extraction (Bioneer Co., Korea). Specimens were thawed; 20 µL Proteinase K and 200 µL binding buffer were added to 200 µL of samples, after mixing, they were incubated at 60°C for 20 minutes. 100 µL isopropanol was added to mixtures. Lysates were centrifuged at 8000 rpm for 1 minute; washing buffer 1 and then 2 were added to tubes, respectively. After centrifuge, 200 µL elution buffer was added and centrifuged at 8000 rpm for 1 minute, finally. Eluted genomic DNA stored at -20°C for further analysis. PCR: For preparation Master mix (1 X); 11.6 µL PCR Master mix was added to 0.4 µL hot start Taq polymerase. 8 µL of template DNA was added into each PCR reaction tubes containing 12 µL Master mix. The PCR grade water (8 µL) and 8 µL of positive control were considered as negative and positive controls, respectively. Amplications were carried out in master cycler (Eppendorf Co., Germany). Denaturation was performed at 95°C for 3 minutes, followed by 35 cycles (94°C for 30 seconds, 58°C for 40 seconds and 67°C for 40 seconds) and 72°C for 5 minutes. For nested PCR; we transferred 15 µL PCR Master mix 2X, 0.2 µL Taq polymerase and 5 µL of the first PCR products to each PCR reaction tubes. Amplication program was as follow: 95°C for 3 minutes, followed by 35 cycles (94°C for 30 seconds, 56°C for 40 seconds and 67°C for 40 seconds) and 72°C for 5 minutes. The final PCR products were analyzed on 2% agarose gel electrophoresis stained with ethidium bromide. The nested PCR procedure was used to screen 242 samples (121 vaginal and 121 endocervix samples). The first specific primer sets was derived from sequences of the common endogenous plasmid of C. trachomatis (15), 517 base pair (bp) amplified products with all known C. trachomatis serovars (F = GGACAAATCGTATCTCGG, R = GAAACCAACTCTACGCTG) (13). The second primer set was F = ATTGCTTGAGCGTATAAAGG and R = TGCTATAATCACGAAATTAC; the amplified product was 250 bp.

4. Results

We enrolled 121 women aged between 17 - 38 years old with 21% miscarriages in the past, referred to the Medical Centers. There was a significant association between the number of abortions and abnormal vaginal discharge with C. trachomatis infection (P = 0.00 and P = 0.001, respectively). In addition, sexual infection among patients with more than 3 intercourses to less than 3 intercourses per week showed significant difference (P < 0.05). The base line data are collected in Table 1.

Table 1. Baseline Data of Cases
DataNumber of Intercourse during a WeekHistory of PregnancyHistory of AbortionVaginal SecretionLower Abdominal PainContraceptive Route
Case≥ 3< 3YesNoYesNoYesNoYesNoNo aOCP aIUD aCond a
Patients, (%)6535841621793278148657121813

aAbbreviations: NO, nothing; OCP, oral contraceptive; IUD, intrauterine device; Cond, condom

The infected samples were identified using nested PCR. Detected rate of C. trachomatis, Mycoplasma genitalium and Ureaplasma urealyticum in the cervixes were 13.25%, 16.5% and 10%, respectively. Frequencies cervical infection with C. trachomatis, M. genitalium and U. urealyticum were 19%, 25% and 25%, respectively (Table 2).

Table 2. Frequency of Infected Sites (by PCR Method)
Infected Site by BacteriaEndocervixVaginal Infection
Negative, %Positive, %Positive, %Negative, %
Chlamydia trachomatis86.7513.251981
Mycoplasma genitalium83.516.52575
Ureaplasma urealyticum9010%25%75

5. Discussion

In study of Kucinskiene et al. (2006) the prevalence of C. trachomatis in Europe was 4.1 to 25% (16). Sotoodeh Jahromi et al. in 2005, reported that the prevalence of C. trachomatis in women with abortion was 25.45% (7). Also, in other studies in different places in Iran, the prevalence of C. trachomatis in different cities was 22% (Tehran), 10% (Bandar Abbas) and 6.5% (Shiraz) (17). It seems that these differences are related to sampling and testing methods, sexual behavior, number of partners, hygiene and barrier contraception during intercourse. Meanwhile, adequate specimen has very important role; Welsh and et al. compared the influence of adequate and inadequate sampling on prevalence; 14.2% for adequate and 4.3% for inadequate specimens (18). In our study, abnormal vaginal discharge was the common complaint in women with C. tracomatis. The result was the same as the results of Mohammadzadeh et al. study (19). Mucopurulent discharge in Taylor and Haggerty study was 37% (20). C. trachomatis was introduced as one of the spontaneous abortion etiological factors (21-23). Wilkowska-Trojniel et al. showed Anti-chlamydial IgA and IgG antibody levels were 7.9% and 21.1% in cases with one miscarriage and were 4.5% and 36.4% in women with two or more miscarriages (2). Elias et al. reported that the rate of cervical chlamydial infection in women with imminent abortion was 26.4% (24). The proportion of abortion in our study was 28.6%. This difference could be related to how sampling and methodology were conducted. Globally, C. trachomatis is the most common agent of genital infection (16). Therefore, to prevent abortion, pregnant women (with or without symptom) and high-risk group (male or female) must be screened for C. trachomatis. In this study specimens collection were done by swabs but it was not a comfortable method for women patients then we offer urine collection, since it was not invasive. However, it is a simple method and do not need trained personnel but it may be missed other microbial agents such as genital warts and herpes.

Acknowledgements

Footnotes

References

  • 1.

    Salari MH, Badami N. The rate of Chlamydia trachomatis, Mycoplasma hominis and Ureaplasma urealyticum in females with habitual abortion and its comparison with control group. Acta Medica Iranica. 2002; 40(1-2) : 79 -82

  • 2.

    Wilkowska-Trojniel M, Zdrodowska-Stefanow B, Ostaszewska-Puchalska I, Redzko S, Przepiesc J, Zdrodowski M. The influence of Chlamydia trachomatis infection on spontaneous abortions. Adv Med Sci. 2009; 54(1) : 86 -90 [DOI][PubMed]

  • 3.

    Keegan H, Ryan F, Malkin A, Griffin M, Lambkin H. Chlamydia trachomatis detection in cervical PreservCyt specimens from an Irish urban female population. Cytopathology. 2009; 20(2) : 111 -6 [DOI][PubMed]

  • 4.

    Geisler WM. Approaches to the management of uncomplicated genital Chlamydia trachomatis infections. Expert Rev Anti Infect Ther. 2004; 2(5) : 771 -85 [PubMed]

  • 5.

    Valadan M, Yarandi F, Eftekhar Z, Danvish S, Fathollahi MS, Mirsalehian A. Chlamydia trachomatis and cervical intraepithelial neoplasia in married women in a Middle Eastern community. East Mediterr Health J. 2010; 16(3) : 304 -7 [PubMed]

  • 6.

    Mardh PA. Influence of infection with Chlamydia trachomatis on pregnancy outcome, infant health and life-long sequelae in infected offspring. Best Pract Res Clin Obstet Gynaecol. 2002; 16(6) : 847 -64 [PubMed]

  • 7.

    Sotoodeh Jahromi A, Farjam MR, Mogharrab F, Amiryan M, Makiani MJ, et al. Chlamydia trachomatis in women with ful-term deliveries and women with abortion. Am J Infect Dis. 2010; 6 : 66 -9

  • 8.

    Stamm Walter E. Principles and Practice of Infectious Diseases . 2005; : 2236 -56

  • 9.

    Hodinka RL, Davis CH, Choong J, Wyrick PB. Ultrastructural study of endocytosis of Chlamydia trachomatis by McCoy cells. Infect Immun. 1988; 56(6) : 1456 -63 [PubMed]

  • 10.

    Black CM. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev. 1997; 10(1) : 160 -84

  • 11.

    Stamm WE. Chlamydia trachomatis infections: progress and problems. J Infect Dis. 1999; 179 Suppl 2 -3

  • 12.

    Young H, Moyes A, Horn K, Scott GR, Patrizio C, Sutherland S. PCR testing of genital and urine specimens compared with culture for the diagnosis of chlamydial infection in men and women. Int J STD AIDS. 1998; 9(11) : 661 -5 [PubMed]

  • 13.

    Claas HC, Wagenvoort JH, Niesters HG, Tio TT, Van Rijsoort-Vos JH, Quint WG. Diagnostic value of the polymerase chain reaction for Chlamydia detection as determined in a follow-up study. J Clin Microbiol. 1991; 29(1) : 42 -5 [PubMed]

  • 14.

    Van Der Pol B, Quinn TC, Gaydos CA, Crotchfelt K, Schachter J, Moncada J, et al. Multicenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection of Chlamydia trachomatis. J Clin Microbiol. 2000; 38(3) : 1105 -12 [PubMed]

  • 15.

    Sriprakash KS, Macavoy ES. Characterization and sequence of a plasmid from the trachoma biovar of Chlamydia trachomatis. Plasmid. 1987; 18(3) : 205 -14

  • 16.

    Kučinskienė V, Šutaitė I, Valiukevičienė S, Milašauskienė Ž, Domeika M. Prevalence and risk factors of genital Chlamydia trachomatis infection. Medicina (Kaunas). 2006; 42(10) : 885 -94

  • 17.

    Fallah F, Kazemi B, Goudarzi H, Badami N, Doostdar F, Ehteda A, et al. Detection of Chlamydia trachomatis from urine specimens by PCR in women with cervicitis. Iran J Public Health. 2005; 34(2)

  • 18.

    Welsh LE, Quinn TC, Gaydos CA. Influence of endocervical specimen adequacy on PCR and direct fluorescent-antibody staining for detection of Chlamydia trachomatis infections. J Clin Microbiol. 1997; 35(12) : 3078 -81 [PubMed]

  • 19.

    Mohammadzadeh M, Amirmozafari N, Shayanfar N, Ranjbar R, Rahbar M. Prevalence of Chlamydia trachomatis infections in symptomatic women by polymerase chain reaction(PCR) immunofluorescence and Giemsa stain. Afr J Biotech. 2011; 10(34) : 6601 -5

  • 20.

    Taylor BD, Haggerty CL. Management of Chlamydia trachomatis genital tract infection: screening and treatment challenges. Infect Drug Resist. 2011; 4 : 19 -29 [DOI][PubMed]

  • 21.

    Abdul-Karim ET, Abdul-Muhymen N, Al-Saadie M. Chlamydia trachomatis and rubella antibodies in women with full-term deliveries and women with abortion in Baghdad. East Mediterr Health J. 2009; 15(6) : 1407 -11 [PubMed]

  • 22.

    Avasthi K, Garg T, Gupta S, Grewal RK, Ram S. A study of prevalence of Chlamydia trachomatis infection in women with first trimester pregnancy losses. Indian J Pathol Microbiol. 2003; 46(1) : 133 -6 [PubMed]

  • 23.

    Bakhtiari A, Firoozjahi A. Chlamydia trachomatis infection in women attending health centres in Babol: prevalence and risk factors. East Mediterr Health J. 2007; 13(5) : 1124 -31 [PubMed]

  • 24.

    Elias M, Choroszy-Krol I. [Chlamydia trachomatis during genital tract infection and in imminent abortion]. Ginekol Pol. 1995; 66(9) : 513 -7 [PubMed]

  • COMMENTS

    LEAVE A COMMENT HERE: